X

Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use

Medical services; Medical services, namely, gene therapy services

Technology transfer services, namely, licensing of intellectual property